Idiopathic Multicentric Castleman's Disease
4 clinical trials · Condition
◉ Watch Idiopathic Multicentric Castleman's Disease
| Record | Firm | Date |
|---|---|---|
| Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease (NCT04838860) | RECORDATI GROUP | 2021-03-31 |
| Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial (NCT04743687) | Peking Union Medical College Hospital | 2021-01-01 |
| BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD) (NCT03982771) | Peking Union Medical College Hospital | 2019-01-01 |
Track Idiopathic Multicentric Castleman's Disease automatically
Every clearance here is in the API, with alerts when new ones post.